Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Report this comment to a moderator

Please fill in the form below if you think a comment is unsuitable. Please indicate which comment is of concern and why. Your comments will be sent to our moderator for review.

Report comment to moderator

MandatoryRequired fields.

Headline

Pilot programme could help 20,000 patients receive subsidised medical cannabis

Comment

So what can be done to keep it a) from becoming monopolized by the big cannaPharma (eg. GW pharmaceuticals).. And where was this concern and care when opioids came on the market. How many trials were scrutinised?? Less than cannabis o assure you because a big pharma co was behind it. And their side effect ..death. cannabis side effect.. very high for a while! Not one death reported.. EVER. Let's stop this silliness. Regulate with some courage and actual concern to patients not getting access

Posted date

8 NOV 2019

Posted time

14:17

Mandatory
Mandatory
Mandatory
Mandatory

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.